|Articles|January 1, 1996
Supplements and Featured Publications
- Advances in Cardiovascular Therapeutics: Trends in ACE Inhibition
- Volume 2
- Issue 1 Suppl
Do All Patients Deserve Treatment with Angiotensin Converting Enzyme Inhibitors after Myocardial Infarction? An Argument to Treat only High-Risk Patients
Author(s)Stephen G. Ball, PhD
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
4
5 Things to Know About the Oral GLP-1 Era
5
